LATEST NEWS

New vaccine design pipeline could protect against emerging SARS-CoV-2 variants and more
LJI scientists study cockroach allergies to discover how allergy immunotherapies really work
As Chikungunya spreads into new regions, LJI scientists share a first look at how human T cells target the virus. Their findings may shed light on how viruses can trigger chronic disease.
“We found a missing puzzle piece that represents one possible reason why immunization efforts against CMV have been unsuccessful.”
LJI scientists discover that T cells may allow for early detection of Parkinson's cases—years before motor symptoms development.
LJI scientists find that a person's past vaccine response—not age, sex, or vaccine dose—is the best predictor of future vaccine responses
By studying Chikungunya virus, LJI scientists shed light on how immune responses to viral infections may lead to persistent symptoms of autoimmune disease.
How sex-based differences shape the immune system—and what these discoveries mean for the future of medicine
“This study illustrated a profound difference between the immune systems of men and women.”